26 September 2016
Deals | France & China | M&A
Gide is advising TINAVI Medical Technologies, a Beijing-based group specializing in innovative medical devices and listed on Beijing’s NEEQ Stock Market, on its investment in Spineway, a company listed on Alternext specialized in implants and surgical instruments for treating spinal column disorders.
The transaction will consist in an issuance of shares with stock subscription warrants attached (ABSA) reserved entirely to TINAVI Medical Technologies, which will allow TINAVI Medical Technologies to hold 9.09% of the share capital and 5.04% of the voting rights of Spineway and, in case of exercise of the warrants, 17.36% of the share capital and 10.59% of the voting rights of Spineway.
The Gide team advising TINAVI Medical Technologies on this transaction comprises Antoine Tézenas du Montcel (partner), Régis Henry and Elise Bernard in Paris and Ronan Diot (counsel) in Beijing.